AtheroMed initiates enrollment in Phoenix Atherectomy catheter trial for PAD

Links shared publicly online about this topic.

891
total visits

AtheroMed initiates enrollment in Phoenix Atherectomy catheter trial for PAD

AtheroMed, Inc. announced today the start of enrollment in the EASE study to evaluate the safety and effectiveness of the Phoenix Atherectomy" catheter, a minimally invasive device for the treatment of peripheral arterial disease (PAD) in the legs. EASE - Endovascular Atherectomy Safety and Effectiveness - is an FDA-approved Investigational Device Exemption (IDE) clinical trial that will enroll 90 patients at up to 20 clinical sites.

View full resource at news-medical.net

Tags: Circulatory Disorders, Disease and Condition, Clinical Trial